Enteric fever, primarily caused by Salmonella Typhi and Paratyphi, is a systemic disease that continues to pose significant health challenges in many parts of the world. This article aims to provide an updated approach to the diagnosis and management of enteric fever.
Diagnosis of enteric fever has traditionally relied on blood, bone marrow, or stool cultures. However, these methods are time-consuming and often yield false negatives. Recent advancements have introduced rapid diagnostic tests (RDTs) like Typhidot and Tubex TF, which detect IgM and IgG antibodies. Although they offer quick results, their sensitivity and specificity vary. Molecular techniques such as Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS) have also shown promise, providing high sensitivity and specificity.
The mainstay of treatment for enteric fever is antibiotic therapy. The choice of antibiotic is guided by local antimicrobial susceptibility patterns. Fluoroquinolones, third-generation cephalosporins, and azithromycin are currently the drugs of choice. However, the emergence of extensively drug-resistant Salmonella strains necessitates the prudent use of antibiotics. Adjunctive therapy with corticosteroids may be beneficial in severe cases.
Vaccination forms an integral part of enteric fever prevention. The WHO recommends the use of Ty21a and Vi polysaccharide vaccines in endemic areas. Recently, a new conjugate vaccine (TCV) has been prequalified by WHO, showing high efficacy and longer duration of protection. Additionally, safe water and food practices, improved sanitation, and public health surveillance are crucial for prevention.
In conclusion, the diagnosis and treatment of enteric fever require a multifaceted approach. While rapid diagnostic tests and molecular techniques improve diagnostic accuracy, the judicious use of antibiotics is key in treatment. Vaccination, along with improved sanitation practices, plays a vital role in prevention. Staying abreast of these updated strategies is essential for healthcare professionals in managing this significant global health issue.
1.
When does a melanoma metastasize? Implications for management
2.
Asandeutertinib Tops Osimertinib for NSCLC With Brain Mets
3.
Mammography with AI support is a secure method for detecting breast cancer.
4.
Compared to previous estimates, a greater number of patients participate in cancer treatment trials.
5.
The biology of cancer as well as potential treatment options are examined by experts.
1.
Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome
2.
HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review
3.
Tumor-Associated Stroma Regeneration Models
4.
Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025
5.
Immunotherapy Tolerance in Older Adults With Cancer
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation